Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for U.S. Food and Drug Administration approval and postmarket surveillance of endoscopic devices.
PMID : 32750323 ·
N, a, s, i, r, , S, a, l, e, e, m, ;, , M, o, h, a, m, m, a, d, , K, , I, s, m, a, i, l, ;, , C, l, a, u, d, i, o, , R, , T, o, m, b, a, z, z, i, ;, , S, a, r, t, h, a, k, , S, o, i, n, ;, , S, a, n, k, e, t, , S, , D, h, r, u, v, a
Publicité
Résumé
Since the first widely reported case cluster of duodenoscope-associated transmission of carbapenem-resistant Enterobacteriaceae (CRE) in 2013 that affected 38 patients, similar outbreaks have occurred throughout the world. The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention, professional gastroenterology societies, and endoscope manufacturers have taken multiple steps to address this issue. Unlike prior outbreaks attributed to lapses in cleaning and reprocessi
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.